Mira Pharmaceuticals Inc (MIRA)
1.17
+0.10
(+9.35%)
USD |
NASDAQ |
Sep 27, 16:00
1.12
-0.05
(-4.27%)
After-Hours: 20:00
Mira Pharmaceuticals Cash from Financing (Quarterly): 0.159M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.159M |
March 31, 2024 | -0.0243M |
December 31, 2023 | -0.2307M |
September 30, 2023 | 7.605M |
June 30, 2023 | 0.6843M |
Date | Value |
---|---|
March 31, 2023 | 0.7257M |
December 31, 2022 | 1.139M |
September 30, 2022 | 0.6764M |
June 30, 2022 | -0.025M |
March 31, 2022 | 1.356M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.2307M
Minimum
Dec 2023
7.605M
Maximum
Sep 2023
1.206M
Average
0.6804M
Median
Cash from Financing (Quarterly) Benchmarks
Viking Therapeutics Inc | 2.905M |
Perspective Therapeutics Inc | 122.08M |
Alaunos Therapeutics Inc | 0.00 |
MEI Pharma Inc | -0.208M |
Oragenics Inc | 0.8212M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -0.8639M |
Free Cash Flow | -4.710M |
Free Cash Flow Per Share (Quarterly) | -0.0584 |
Free Cash Flow Yield | -25.60% |